Zevra Therapeutics
Manufacturing · Florida, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1180 Celebration Blvd Ste 103, Celebrati...Phone Number
(888) 958-1253Website
www.zevra.comRevenue
$136.1 MillionStock Symbol
ZVRAIndustry
About Zevra Therapeutics
Zevra Therapeutics, founded in 2006, is a pharmaceutical company specializing in rare disease therapeutics. The company focuses on developing life-changing treatments for patients with significant unmet medical needs. Zevra's approach involves collaboration with thought leaders, physicians, patients, and advocacy groups throughout clinical and regulatory development processes. The company utilizes innovative problem-solving methods to overcome complex development challenges in bringing therapies to market. With a data-driven methodology and transparent approach, Zevra Therapeutics works to make essential medications accessible to patients with rare conditions.Explore more
SIC Code 28,283NAICS Code 32,325Ticker NASDAQ: ZVRAShow moreZevra Therapeutics Org Chart
Compare Similar Companies to Zevra Therapeutics
Compare insights from companies similar to Zevra Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Zevra Therapeutics Tech Stack
A closer look at the technologies used by Zevra Therapeutics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Zevra Therapeutics
Sign Up For FreeTo access detailed company insights
Zevra Therapeutics, founded in 2006, is a pharmaceutical company specializing in rare disease therapeutics. The company focuses on developing life-changing treatments for patients with significant unmet medical needs. Zevra's approach involves collaboration with thought leaders, physicians, patients, and advocacy groups throughout clinical and regu... Read More
